Laurus Labs Ltd
LAURUSLABSLaurus Labs Ltd
LAURUSLABSPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
122.32 | 5.68 | 0.47% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.18 | 5.82 | 0.57% |
Forecast & Ratings
Detailed Forecastfrom 11 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Laurus Labs Private Ltd is a research and development pharmaceutical company which manufactures active pharmaceutical ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 1,360.66 | 1,781.94 | 1,937.03 | 2,085.36 | 2,308.07 | 2,837.64 | 4,837.17 | 4,950.87 | 6,046.55 | 4,991.58 | ||||||||||
Raw Materials | 912.82 | 1,033.24 | 1,031.67 | 1,088.41 | 1,267.63 | 1,629.55 | 2,455.20 | 2,414.94 | 2,752.28 | 4,160.51 | ||||||||||
Power & Fuel Cost | 49.86 | 57.96 | 66.27 | 94.21 | 109.37 | 136.77 | 157.75 | 204.47 | 324.10 | |||||||||||
Employee Cost | 126.01 | 175.46 | 204.73 | 238.14 | 276.33 | 320.77 | 397.04 | 469.55 | 557.43 | |||||||||||
Selling & Administrative Expenses | 48.38 | 67.97 | 92.25 | 96.07 | 140.99 | 189.38 | 239.88 | 276.15 | 291.00 | |||||||||||
Operating & Other expenses | -10.65 | 80.75 | 102.10 | 126.03 | 141.61 | -9.30 | 12.96 | 148.03 | 523.55 | |||||||||||
EBITDA | 234.24 | 366.56 | 440.01 | 442.50 | 372.14 | 570.47 | 1,574.34 | 1,437.73 | 1,598.19 | 831.07 | ||||||||||
Depreciation/Amortization | 61.53 | 86.41 | 105.98 | 125.45 | 164.19 | 187.27 | 205.07 | 251.49 | 324.08 | 369.34 | ||||||||||
PBIT | 172.71 | 280.15 | 334.03 | 317.05 | 207.95 | 383.20 | 1,369.27 | 1,186.24 | 1,274.11 | 461.73 | ||||||||||
Interest & Other Items | 106.16 | 111.11 | 99.90 | 79.64 | 88.19 | 89.59 | 68.16 | 102.39 | 165.17 | 185.50 | ||||||||||
PBT | 66.55 | 169.04 | 234.13 | 237.41 | 119.76 | 293.61 | 1,301.11 | 1,083.85 | 1,108.94 | 276.23 | ||||||||||
Taxes & Other Items | -1.80 | 35.30 | 43.86 | 69.81 | 25.99 | 38.34 | 317.53 | 256.33 | 318.83 | 88.31 | ||||||||||
Net Income | 68.35 | 133.74 | 190.27 | 167.60 | 93.77 | 255.27 | 983.58 | 827.52 | 790.11 | 187.92 | ||||||||||
EPS | 0.44 | 0.86 | 1.81 | 3.17 | 1.77 | 4.79 | 18.36 | 15.41 | 14.69 | 3.49 | ||||||||||
DPS | 0.00 | 0.10 | 0.30 | 0.30 | 0.30 | 0.50 | 2.00 | 2.00 | 2.00 | 1.60 | ||||||||||
Payout ratio | 0.00 | 0.12 | 0.17 | 0.09 | 0.17 | 0.10 | 0.11 | 0.13 | 0.14 | 0.46 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Laurus Labs Ltd | 29.09 | 5.68 | 0.47% |
Sun Pharmaceutical Industries Ltd | 43.12 | 6.16 | 0.76% |
Cipla Ltd | 38.78 | 4.58 | 0.63% |
Dr Reddy's Laboratories Ltd | 21.96 | 4.25 | 0.67% |
Price Comparison
Compare LAURUSLABS with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
Mutual Funds Holding Trend
Increased Mutual Fund Holding
In last 3 months, mutual fund holding of the company has increased by 1.10%
Top 5 Mutual Funds holding Laurus Labs Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Mirae Asset ELSS Tax Saver Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.1489% | Percentage of the fund’s portfolio invested in the stock 1.28% | Change in the portfolio weight of the stock over the last 3 months 1.28% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 55/88 (+24) |
Mirae Asset Large & Midcap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.8392% | Percentage of the fund’s portfolio invested in the stock 0.60% | Change in the portfolio weight of the stock over the last 3 months 0.60% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 67/100 (+30) |
Mirae Asset Midcap Fund - Direct Plan - Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.6752% | Percentage of the fund’s portfolio invested in the stock 1.13% | Change in the portfolio weight of the stock over the last 3 months -0.15% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 56/81 (-2) |
Compare 3-month MF holding change on Screener
smallcases
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have Laurus Labs Ltd
Events
Dividend Trend
No Dividend Cuts
LAURUSLABS has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.47%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹4.69 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateNov 2, 2023
Dividend/Share
₹0.40
Ex DateEx Date
Nov 2, 2023
Cash Dividend
Ex DateEx DateMay 10, 2023
Dividend/Share
₹1.20
Ex DateEx Date
May 10, 2023
Cash Dividend
Ex DateEx DateNov 3, 2022
Dividend/Share
₹0.80
Ex DateEx Date
Nov 3, 2022
Cash Dividend
Ex DateEx DateMay 10, 2022
Dividend/Share
₹1.20
Ex DateEx Date
May 10, 2022
Cash Dividend
Ex DateEx DateNov 17, 2021
Dividend/Share
₹0.80
Ex DateEx Date
Nov 17, 2021
News & Opinions
News Video
Goldman Sachs Initiates Buy On Syngene, Neuland Labs & A Sell Rating On Laurus Labs | CNBC TV18
1 week ago•CNBC-TV18
Trade setup for Tuesday: 15 things to know before opening bell
3 weeks ago•Moneycontrol
Laurus Labs plunges on yet another bad quarter, management commentary ‘unsurprising’
2 months ago•Moneycontrol
Laurus Labs Shares Fall After U.S. FDA Observations On Andhra Unit
4 months ago•Bloomberg Quint
News Video
Sunteck Realty Under Pressure After A Big Block Deal, Laurus Labs Slips Post US FDA Observations
4 months ago•CNBC-TV18
U.S. regulator inspects Indian pharma firms
4 months ago•The Hindu
Titan, Britannia, Tata Steel — Buy, Sell Or Hold? AskBQ
5 months ago•Bloomberg Quint
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 23.73%, vs industry avg of 8.36%
Increasing Market Share
Over the last 5 years, market share increased from 1.03% to 1.85%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 36.36%, vs industry avg of 9.82%